PT2935312T - Péptidos enquanto agonistas da oxitocina - Google Patents

Péptidos enquanto agonistas da oxitocina

Info

Publication number: PT2935312T
Authority: PT; Portugal
Prior art keywords: peptides; oxytocin agonists; oxytocin; agonists
Prior art date: 2012-12-21

Application number

PT13814079T

Other languages

English (en)

Inventor

Bissantz Caterina

Grundschober Christophe

Bleicher Konrad

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2013-12-17

Publication date

2018-10-26

2013-12-17 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2018-10-26 Publication of PT2935312T publication Critical patent/PT2935312T/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

PT13814079T 2012-12-21 2013-12-17 Péptidos enquanto agonistas da oxitocina PT2935312T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP12199012		2012-12-21

Publications (1)

Publication Number	Publication Date
PT2935312T true PT2935312T (pt)	2018-10-26

Family

ID=47471593

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT13814079T PT2935312T (pt)	2012-12-21	2013-12-17	Péptidos enquanto agonistas da oxitocina

Country Status (34)

Country	Link
US (1)	US9868766B2 (pt)
EP (1)	EP2935312B1 (pt)
JP (1)	JP6067878B2 (pt)
KR (1)	KR101819804B1 (pt)
CN (1)	CN104870466B (pt)
AR (1)	AR094225A1 (pt)
AU (1)	AU2013363768B2 (pt)
BR (1)	BR112015014010A2 (pt)
CA (1)	CA2895150C (pt)
CL (1)	CL2015001724A1 (pt)
CR (1)	CR20150271A (pt)
DK (1)	DK2935312T3 (pt)
EA (1)	EA026687B1 (pt)
ES (1)	ES2690317T3 (pt)
HK (1)	HK1208477A1 (pt)
HR (1)	HRP20181569T1 (pt)
HU (1)	HUE039848T2 (pt)
IL (1)	IL239519A (pt)
LT (1)	LT2935312T (pt)
MA (1)	MA38272A1 (pt)
MX (1)	MX358684B (pt)
MY (1)	MY176398A (pt)
NZ (1)	NZ708175A (pt)
PE (1)	PE20151446A1 (pt)
PH (1)	PH12015501145B1 (pt)
PL (1)	PL2935312T3 (pt)
PT (1)	PT2935312T (pt)
RS (1)	RS57690B1 (pt)
SG (1)	SG11201504883PA (pt)
SI (1)	SI2935312T1 (pt)
TW (1)	TWI558726B (pt)
UA (1)	UA119034C2 (pt)
WO (1)	WO2014095773A1 (pt)
ZA (1)	ZA201504186B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10039777B2 (en)	2012-03-20	2018-08-07	Neuro-Lm Sas	Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
UA111305C2 (uk)	2012-12-21	2016-04-11	Пфайзер Інк.	Конденсовані лактами арилу та гетероарилу
KR101819804B1 (ko)	2012-12-21	2018-01-17	에프. 호프만-라 로슈 아게	옥시토신 작용제로서의 펩타이드
EP3421482A1 (en)	2012-12-21	2019-01-02	Alios Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
KR102116107B1 (ko)	2013-12-30	2020-05-28	삼성디스플레이 주식회사	표시 장치
WO2015106200A2 (en)	2014-01-10	2015-07-16	Cornell University	Dipeptides as inhibitors of human immunoproteasomes
PE20161559A1 (es)	2014-06-03	2017-01-12	Hoffmann La Roche	Peptidos como agonistas de la oxitocina
AP2016009605A0 (en)	2014-06-17	2016-12-31	Pfizer	Substituted dihydroisoquinolinone compounds
US10588980B2 (en)	2014-06-23	2020-03-17	Novartis Ag	Fatty acids and their use in conjugation to biomolecules
TR201815872T4 (tr) *	2014-08-07	2018-11-21	Hoffmann La Roche	Oksitosin analoglarının hazırlanması için prosesler.
WO2016028571A2 (en) *	2014-08-18	2016-02-25	Cornell University	Dipeptidomimetics as inhibitors of human immunoproteasomes
US10441627B2 (en)	2014-09-19	2019-10-15	Ferring B.V.	Method of treating prader-willi syndrome
EP3362754B1 (en)	2015-10-15	2021-12-22	Cornell University	Proteasome inhibitors and uses thereof
EP3694605A4 (en)	2017-10-11	2021-10-27	Cornell University	PEPTIDOMIMETIC PROTEASOME INHIBITORS
WO2020061414A1 (en)	2018-09-20	2020-03-26	Levo Therapeutics, Inc.	Stable intranasal formulations of carbetocin
TW202034899A (zh)	2018-09-20	2020-10-01	克里斯托弗Ｓ布萊恩特	卡貝縮宮素藥品及其製備方法
WO2021126990A1 (en) *	2019-12-16	2021-06-24	The Scripps Research Institute	Oxytocin derivatives with improved properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8673841B2 (en)	2008-03-31	2014-03-18	Ferring B.V.	Oxytocin analogues
TWI463990B (zh) *	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
ES2509270T3 (es) *	2009-10-01	2014-10-17	The University Of Sydney	Terapia y prevención del alcoholismo
KR101819804B1 (ko)	2012-12-21	2018-01-17	에프. 호프만-라 로슈 아게	옥시토신 작용제로서의 펩타이드

2013
- 2013-12-17 KR KR1020157016376A patent/KR101819804B1/ko active IP Right Grant
- 2013-12-17 CN CN201380066617.7A patent/CN104870466B/zh not_active Expired - Fee Related
- 2013-12-17 WO PCT/EP2013/076783 patent/WO2014095773A1/en active Application Filing
- 2013-12-17 AU AU2013363768A patent/AU2013363768B2/en not_active Ceased
- 2013-12-17 MX MX2015007365A patent/MX358684B/es active IP Right Grant
- 2013-12-17 DK DK13814079.3T patent/DK2935312T3/en active
- 2013-12-17 PL PL13814079T patent/PL2935312T3/pl unknown
- 2013-12-17 ES ES13814079.3T patent/ES2690317T3/es active Active
- 2013-12-17 HU HUE13814079A patent/HUE039848T2/hu unknown
- 2013-12-17 RS RS20181124A patent/RS57690B1/sr unknown
- 2013-12-17 PE PE2015001058A patent/PE20151446A1/es unknown
- 2013-12-17 SI SI201331190T patent/SI2935312T1/sl unknown
- 2013-12-17 MA MA38272A patent/MA38272A1/fr unknown
- 2013-12-17 SG SG11201504883PA patent/SG11201504883PA/en unknown
- 2013-12-17 EP EP13814079.3A patent/EP2935312B1/en active Active
- 2013-12-17 JP JP2015548420A patent/JP6067878B2/ja not_active Expired - Fee Related
- 2013-12-17 BR BR112015014010A patent/BR112015014010A2/pt not_active IP Right Cessation
- 2013-12-17 CA CA2895150A patent/CA2895150C/en not_active Expired - Fee Related
- 2013-12-17 MY MYPI2015001585A patent/MY176398A/en unknown
- 2013-12-17 LT LTEP13814079.3T patent/LT2935312T/lt unknown
- 2013-12-17 UA UAA201506906A patent/UA119034C2/uk unknown
- 2013-12-17 NZ NZ708175A patent/NZ708175A/en not_active IP Right Cessation
- 2013-12-17 EA EA201591078A patent/EA026687B1/ru not_active IP Right Cessation
- 2013-12-17 PT PT13814079T patent/PT2935312T/pt unknown
- 2013-12-20 TW TW102147655A patent/TWI558726B/zh not_active IP Right Cessation
- 2013-12-20 AR ARP130104962A patent/AR094225A1/es unknown
2015
- 2015-05-21 CR CR20150271A patent/CR20150271A/es unknown
- 2015-05-22 PH PH12015501145A patent/PH12015501145B1/en unknown
- 2015-06-10 ZA ZA2015/04186A patent/ZA201504186B/en unknown
- 2015-06-18 US US14/743,009 patent/US9868766B2/en active Active
- 2015-06-18 CL CL2015001724A patent/CL2015001724A1/es unknown
- 2015-06-18 IL IL239519A patent/IL239519A/en active IP Right Grant
- 2015-09-18 HK HK15109189.5A patent/HK1208477A1/xx not_active IP Right Cessation
2018
- 2018-10-02 HR HRP20181569TT patent/HRP20181569T1/hr unknown

Also Published As

Publication number	Publication date
CN104870466A (zh)	2015-08-26
KR20150085845A (ko)	2015-07-24
US20150284434A1 (en)	2015-10-08
WO2014095773A1 (en)	2014-06-26
CR20150271A (es)	2015-08-28
MY176398A (en)	2020-08-05
MX358684B (es)	2018-08-31
PL2935312T3 (pl)	2018-12-31
KR101819804B1 (ko)	2018-01-17
SG11201504883PA (en)	2015-07-30
TWI558726B (zh)	2016-11-21
JP6067878B2 (ja)	2017-01-25
PH12015501145A1 (en)	2015-08-10
TW201429994A (zh)	2014-08-01
CA2895150A1 (en)	2014-06-26
CN104870466B (zh)	2018-05-18
EA026687B1 (ru)	2017-05-31
DK2935312T3 (en)	2018-10-22
SI2935312T1 (sl)	2018-11-30
PE20151446A1 (es)	2015-09-28
CL2015001724A1 (es)	2015-10-16
PH12015501145B1 (en)	2015-08-10
AU2013363768A1 (en)	2015-06-04
MA38272A1 (fr)	2017-07-31
JP2016503044A (ja)	2016-02-01
HUE039848T2 (hu)	2019-02-28
IL239519A (en)	2017-06-29
EA201591078A1 (ru)	2015-10-30
MX2015007365A (es)	2015-10-14
IL239519A0 (en)	2015-08-31
ES2690317T3 (es)	2018-11-20
RS57690B1 (sr)	2018-11-30
AU2013363768B2 (en)	2016-02-04
EP2935312B1 (en)	2018-08-08
BR112015014010A2 (pt)	2017-07-11
EP2935312A1 (en)	2015-10-28
UA119034C2 (uk)	2019-04-25
CA2895150C (en)	2019-11-26
AR094225A1 (es)	2015-07-22
US9868766B2 (en)	2018-01-16
NZ708175A (en)	2020-06-26
HK1208477A1 (en)	2016-03-04
ZA201504186B (en)	2016-04-28
LT2935312T (lt)	2018-10-25
HRP20181569T1 (hr)	2018-11-30

Publication	Publication Date	Title
HRP20181569T1 (hr)	2018-11-30	Peptidi kao agonisti oksitocina
EP2857033A4 (en)	2016-03-30	SKIN-PUNKING PEPTIDE
HK1204797A1 (en)	2015-12-04	Novel anti-siglec15 antibody -siglec-15
EP2812347A4 (en)	2015-11-04	AUTOPHAGIA-INDUCING PEPTIDE
EP2848687A4 (en)	2015-12-02	NOVEL EXPRESSION VECTOR
HK1211486A1 (en)	2016-05-27	Novel uses
GB201218813D0 (en)	2012-12-05	Antimicrobial peptides
GB201220119D0 (en)	2012-12-26	Vector
EP2865686A4 (en)	2016-04-13	EGFR-BINDING PEPTIDE
HK1209138A1 (en)	2016-03-24	Peptides
GB201204868D0 (en)	2012-05-02	Peptides
GB201200555D0 (en)	2012-02-29	Peptide
GB201223114D0 (en)	2013-02-06	Novel peptide
GB201205795D0 (en)	2012-05-16	Vector
GB201201720D0 (en)	2012-03-14	Novel combinations
PT2891663T (pt)	2018-03-20	Péptidos derivados de psf1
HK1201752A1 (en)	2015-09-11	Alternaria peptides
GB201214413D0 (en)	2012-09-26	Festivalstand (festistand)
GB201304493D0 (en)	2013-04-24	Not published
GB201213672D0 (en)	2012-09-12	Protein
GB201220328D0 (en)	2012-12-26	Peptides
GB201211740D0 (en)	2012-08-15	Peptides
GB201207895D0 (en)	2012-06-20	Peptides
GB201200509D0 (en)	2012-02-22	Peptides
GB201221414D0 (en)	2013-01-09	Trans-locating peptide